Single-dose Zika Vaccine Works In Animals: Study
Fahad Shabbir (@FahadShabbir) Published February 02, 2017 | 10:30 PM
PARIS, Feb 2, (APP - UrduPoint / Pakistan Point News - 02nd Feb, 2017 ) - An innovative vaccine made from genetic material protected lab animals from the Zika virus in experiments, scientists reported Thursday, calling it a "promising" lead in fighting the threat to humans.
A single, low dose of the vaccine shielded mice exposed to Zika five months after the shot, they reported in the journal Nature. Monkeys exposed five weeks after they were innoculated were also not affected by the virus.
"We observed rapid and durable protective immunity without adverse events," said senior author Drew Weissman, a professor at the University of Pennsylvania school of Medicine. "This candidate vaccine represents a promising strategy for the global fight against Zika virus." Since Zika erupted on a large scale in mid-2015, more than 1.5 million people have been infected, mostly in Brazil and other countries in South America.
It is transmitted mainly by mosquitos, but also through sex. While the virus causes mild, flu-like symptoms in most people, pregnant women run the risk of giving birth to babies with severe brain damage.
The World Health Organization declared a global health emergency in February last year, and declared it over in mid-November. Several vaccines for Zika are under development, and a few are in the early phases of human trials.
Most vaccines are made from weakened or inert versions of the targeted virus, and seek to trigger a build-up of antibodies to project against full-strength, live virus.
The new vaccine, however, is based on a modified version of genetic material called messenger RNA (mRNA).
Normally the human body would flush out foreign RNA, but the vaccine developed by Weissman's team is designed to pass under the radar of the immune system and enter directly into human cells. Once there, the vaccine RNA is incorporated into the cell's protein-making machinery, where it mimics the action of a live virus vaccine -- building up an immune response.
The RNA-based vaccine has several potential advantages over rivals, the researchers said. Delivered into the blood stream by fat-based nanoparticles, it can be injected just below the skin and is thus easy to administer.
Unlike other vaccines, it only requires one dose, conferring major practical advantages. "If a vaccine is effective after just a single immunisation, the infrastructure needed for its administration can be much simpler," Weissman said in a statement.
Most importantly, perhaps, RNA-based vaccines are non-replicating, meaning they cannot integrate into the host's genetic blueprint, a safety concern that comes with live-virus vaccines. Further tests will determine the vaccine's effects on pregnant animals and unborn foetuses. Weissman said human clinical trials could start within a year.
Recent Stories
Rock-solid Ruud racks up season-leading win in Barcelona
At UN, Iran says it will make Israel 'regret' reprisals
G7 hears calls for 'critical' Ukraine aid
EU seeks to leverage might to confront China, US challenge
5 Customs officials martyred as their vehicle ambushed by terrorists in D I Khan
Pak-New Zealand match called off due to rain
NHA restores traffic on roads affected by recent rains in Balochistan
China to fully support Pakistan's efforts against terrorism: Ambassador Jiang
U.S. envoy calls on Foreign Minister Ishaq Dar
Poland arrests man over suspected plan to kill Zelensky
EU wants to ease youth movement to and from UK
Police foils attempt of supply mainpuri raw material
More Stories From World
-
At G7, Blinken seeks European support for pressure on China
6 hours ago -
Thousands of Bosnian Serbs rally against UN resolution on Srebrenica
6 hours ago -
Israel assault has turned Gaza into 'humanitarian hellscape': UN
7 hours ago -
Husband of ex-Scottish leader charged over alleged embezzlement: police
7 hours ago -
Ecuador hit by power cuts of up to 13 hours amid drought
7 hours ago -
Hugs or bullets? How Mexico presidential rivals aim to curb violence
7 hours ago
-
Kenya military chopper crash kills defence chief, senior officers
8 hours ago -
Biden hails 'incredible' Kennedy family backing against RFK Jr.
8 hours ago -
Maldives court frees jailed ex-president ahead of vote
8 hours ago -
Probe into Portugal ex-PM Costa appears to collapse
8 hours ago -
Jury selection stalls in Trump criminal trial
8 hours ago -
At UN, Iran says it will make Israel 'regret' reprisals
8 hours ago